Format
Sort by
Items per page

Send to

Choose Destination

Best matches for silymarin cancer:

Search results

Items: 1 to 20 of 649

1.

Nano-soldiers ameliorate silibinin delivery: A review study.

Ashrafizadeh M, Ahmadi Z, Mohammadinejad R, Farkhondeh T, Samarghandian S.

Curr Drug Deliv. 2019 Nov 11. doi: 10.2174/1567201816666191112113031. [Epub ahead of print]

PMID:
31721702
2.

Hepatoprotective Mechanisms of Taxifolin on Carbon Tetrachloride-Induced Acute Liver Injury in Mice.

Yang CL, Lin YS, Liu KF, Peng WH, Hsu CM.

Nutrients. 2019 Nov 4;11(11). pii: E2655. doi: 10.3390/nu11112655.

3.

Milk Thistle (PDQ®): Health Professional Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2019 Oct 25.

4.

Metabolism, Transport and Drug-Drug Interactions of Silymarin.

Xie Y, Zhang D, Zhang J, Yuan J.

Molecules. 2019 Oct 14;24(20). pii: E3693. doi: 10.3390/molecules24203693. Review.

5.

Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells.

Kim SH, Choo GS, Yoo ES, Woo JS, Han SH, Lee JH, Jung JY.

Oncol Rep. 2019 Nov;42(5):1904-1914. doi: 10.3892/or.2019.7295. Epub 2019 Aug 28.

6.

Effects of Curcumin and Silymarin on the Shigella dysenteriae and Campylobacter jejuni In vitro.

Kareem SM, Mahmood SS, Hindi NK.

J Gastrointest Cancer. 2019 Sep 4. doi: 10.1007/s12029-019-00301-1. [Epub ahead of print]

PMID:
31482407
7.

Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer.

Hosseinabadi T, Lorigooini Z, Tabarzad M, Salehi B, Rodrigues CF, Martins N, Sharifi-Rad J.

Phytother Res. 2019 Nov;33(11):2849-2861. doi: 10.1002/ptr.6470. Epub 2019 Aug 12. Review.

PMID:
31407422
8.

Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation.

Takke A, Shende P.

Nanomedicine. 2019 Oct;21:102057. doi: 10.1016/j.nano.2019.102057. Epub 2019 Jul 21. Review.

PMID:
31340181
9.

Identification and functional characterisation of Esculentin-2 HYba peptides and their C-terminally amidated analogs from the skin secretion of an endemic frog.

Vineeth Kumar T, Asha R, George S.

Nat Prod Res. 2019 Jul 22:1-5. doi: 10.1080/14786419.2019.1644636. [Epub ahead of print]

PMID:
31328553
10.

Silymarin Enriched Extract (Silybum marianum) Additive Effect on Doxorubicin-Mediated Cytotoxicity in PC-3 Prostate Cancer Cells.

Gioti K, Papachristodoulou A, Benaki D, Havaki S, Beloukas A, Vontzalidou A, Aligiannis N, Skaltsounis AL, Mikros E, Tenta R.

Planta Med. 2019 Aug;85(11-12):997-1007. doi: 10.1055/a-0954-6704. Epub 2019 Jul 9.

PMID:
31288278
11.

Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art.

Di Costanzo A, Angelico R.

Molecules. 2019 Jun 7;24(11). pii: E2155. doi: 10.3390/molecules24112155. Review.

12.

Cold atmospheric plasma and silymarin nanoemulsion synergistically inhibits human melanoma tumorigenesis via targeting HGF/c-MET downstream pathway.

Adhikari M, Kaushik N, Ghimire B, Adhikari B, Baboota S, Al-Khedhairy AA, Wahab R, Lee SJ, Kaushik NK, Choi EH.

Cell Commun Signal. 2019 May 24;17(1):52. doi: 10.1186/s12964-019-0360-4.

13.

Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells.

Zappavigna S, Vanacore D, Lama S, Potenza N, Russo A, Ferranti P, Dallio M, Federico A, Loguercio C, Sperlongano P, Caraglia M, Stiuso P.

Int J Mol Sci. 2019 May 3;20(9). pii: E2190. doi: 10.3390/ijms20092190.

14.

Silymarin-loaded nanostructured lipid carrier gel for the treatment of skin cancer.

Iqbal B, Ali J, Ganguli M, Mishra S, Baboota S.

Nanomedicine (Lond). 2019 May;14(9):1077-1093. doi: 10.2217/nnm-2018-0235. Epub 2019 May 3.

PMID:
31050580
15.

Silymarin: Friend or Foe of UV Exposed Keratinocytes?

Fidrus E, Ujhelyi Z, Fehér P, Hegedűs C, Janka EA, Paragh G, Vasas G, Bácskay I, Remenyik É.

Molecules. 2019 Apr 26;24(9). pii: E1652. doi: 10.3390/molecules24091652.

16.

Intestinal Permeability Study of Clinically Relevant Formulations of Silibinin in Caco-2 Cell Monolayers.

Pérez-Sánchez A, Cuyàs E, Ruiz-Torres V, Agulló-Chazarra L, Verdura S, González-Álvarez I, Bermejo M, Joven J, Micol V, Bosch-Barrera J, Menendez JA.

Int J Mol Sci. 2019 Mar 31;20(7). pii: E1606. doi: 10.3390/ijms20071606.

17.

Silibinin inhibits ultraviolet B radiation-induced mast cells recruitment and bone morphogenetic protein 2 expression in the skin at early stages in Ptch(+/-) mouse model of basal cell carcinoma.

Rigby C, Deep G, Jain A, Orlicky DJ, Agarwal C, Agarwal R.

Mol Carcinog. 2019 Jul;58(7):1260-1271. doi: 10.1002/mc.23008. Epub 2019 Mar 25.

PMID:
30912211
18.

Dendropanax morbifera Ameliorates Thioacetamide-Induced Hepatic Fibrosis via TGF-β1/Smads Pathways.

Yang HY, Kim KS, Lee YH, Park JH, Kim JH, Lee SY, Kim YM, Kim IS, Kacew S, Lee BM, Kwak JH, Yoon K, Kim HS.

Int J Biol Sci. 2019 Feb 13;15(4):800-811. doi: 10.7150/ijbs.30356. eCollection 2019.

19.

Natural Products Mediated Targeting of Virally Infected Cancer.

Fatima I, Kanwal S, Mahmood T.

Dose Response. 2019 Jan 8;17(1):1559325818813227. doi: 10.1177/1559325818813227. eCollection 2019 Jan-Mar. Review.

20.

Milk Thistle (PDQ®): Patient Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2019 Jan 17.

Supplemental Content

Loading ...
Support Center